Open Access Mini Review

Nanoparticulate Carriers of Anticancer Drugs and Therapeutics

Ignác Capek*

Institute of Measurement Sciences SAS, Bratislava, Slovakia

Corresponding Author

Received Date: March 28, 2019;  Published Date: April 08, 2019

Abstract

Nanoscale drug delivery platforms have been developed over the past four decades that have shown promising clinical results in several types of cancer and inflammatory disorders. Nanoparticles have special characteristics of high surface to volume ratio, size controllability, and can be easily functionalized during synthesis [1]. Biodegradable polymer nanoparticles have been used as carriers for drugs, peptides, proteins, vaccines, and nucleotides [2]. Nanoparticles (NPs) can protect drug moieties from degradation and provide sustained drug release.

Citation
Signup for Newsletter
Scroll to Top